ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Institutional Trading Activity


ADAPTIVE BIOTECHNOLOGIES (ADPT) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Polen Capital Management, ARK Invest, Renaissance Technologies LLC, and Viking Global Investors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Polen Capital ManagementBuy34,570325,767$5,290,456
Q3 2025Renaissance Technologies LLCBuy229,800279,700$4,184,312
Q3 2025Polen Capital ManagementBuy148,940291,197$4,356,307
Q3 2025ARK InvestSell-850,8493,165,636$47,357,912
Q2 2025Renaissance Technologies LLCSell-55,98549,900$581,335
Q2 2025Polen Capital ManagementBuy142,257142,257$1,657,294
Q2 2025ARK InvestSell-3,716,0854,016,485$46,792,053
Q1 2025Renaissance Technologies LLCSell-123,900105,885$786,726
Q1 2025ARK InvestSell-1,691,5047,732,570$57,452,995
Q4 2024Renaissance Technologies LLCBuy60,385229,785$1,377,561
Q4 2024ARK InvestSell-2,177,0609,424,074$56,497,324
Q3 2024Renaissance Technologies LLCBuy17,600169,400$867,328
Q3 2024ARK InvestBuy189,13411,601,134$59,397,807
Q2 2024Renaissance Technologies LLCBuy99,217151,800$549,516
Q2 2024ARK InvestBuy850,70411,412,000$41,311,440
Q1 2024Renaissance Technologies LLCBuy1,38352,583$169
Q1 2024ARK InvestSell-2,245,21710,561,296$33,901,759
Q4 2023ARK InvestBuy1,297,20512,806,513$62,751,915
Q3 2023Renaissance Technologies LLCSell-287,30051,200$279
Q3 2023ARK InvestBuy1,055,55611,509,308$62,725,728
Q2 2023Renaissance Technologies LLCSell-55,500338,500$2,271
Q2 2023ARK InvestBuy1,248,62710,453,752$70,144,675
Q1 2023Renaissance Technologies LLCSell-21,800394,000$3,479
Q1 2023ARK InvestBuy3,8809,205,125$81,281,254
Q4 2022Renaissance Technologies LLCSell-42,000415,800$3,177
Q4 2022ARK InvestSell-135,3749,201,245$70,297,512
Q3 2022Renaissance Technologies LLCSell-28,700457,800$3,260
Q3 2022ARK InvestBuy563,6019,336,619$66,477
Q2 2022Renaissance Technologies LLCBuy30,900486,500$3,936
Q2 2022ARK InvestBuy1,063,3528,773,018$68,605

Frequently asked questions about ADPT activity

  • Which institutional owners are buying ADPT?

    Institutional owners buying ADPT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ADPT activity?

    "Buy" means an investor increased their reported position in ADPT compared to the prior reporting period. This reflects growing exposure to ADAPTIVE BIOTECHNOLOGIES (ADPT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ADPT increasing?

    Institutional interest in ADPT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.